Tags

Type your tag names separated by a space and hit enter

Ensuring global access to COVID-19 vaccines.
Lancet. 2020 05 02; 395(10234):1405-1406.Lct

Links

PMC Free PDF

Authors+Show Affiliations

Yamey G
Center for Policy Impact in Global Health, Duke Global Health Institute, Duke University, Durham, NC 27708, USA. Electronic address: gavin.yamey@duke.edu.
Schäferhoff M
Open Consultants, Berlin, Germany.
Hatchett R
Coalition for Epidemic Preparedness Innovations, London, UK.
Pate M
World Bank Group, Washington, DC, USA.
Zhao F
World Bank Group, Washington, DC, USA.
McDade KK
Center for Policy Impact in Global Health, Duke Global Health Institute, Duke University, Durham, NC 27708, USA.

MeSH

BetacoronavirusCOVID-19COVID-19 VaccinesCoronavirus InfectionsDrug DevelopmentDrug IndustryGlobal HealthHealth Services AccessibilityHealth Services Needs and DemandHumansPandemicsPneumonia, ViralResource AllocationSARS-CoV-2Viral Vaccines

Pub Type(s)

Journal Article
Research Support, Non-U.S. Gov't

Language

eng

PubMed ID

32243778

Citation

Yamey, Gavin, et al. "Ensuring Global Access to COVID-19 Vaccines." Lancet (London, England), vol. 395, no. 10234, 2020, pp. 1405-1406.
Yamey G, Schäferhoff M, Hatchett R, et al. Ensuring global access to COVID-19 vaccines. Lancet. 2020;395(10234):1405-1406.
Yamey, G., Schäferhoff, M., Hatchett, R., Pate, M., Zhao, F., & McDade, K. K. (2020). Ensuring global access to COVID-19 vaccines. Lancet (London, England), 395(10234), 1405-1406. https://doi.org/10.1016/S0140-6736(20)30763-7
Yamey G, et al. Ensuring Global Access to COVID-19 Vaccines. Lancet. 2020 05 2;395(10234):1405-1406. PubMed PMID: 32243778.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Ensuring global access to COVID-19 vaccines. AU - Yamey,Gavin, AU - Schäferhoff,Marco, AU - Hatchett,Richard, AU - Pate,Muhammad, AU - Zhao,Feng, AU - McDade,Kaci Kennedy, Y1 - 2020/03/31/ PY - 2020/03/24/received PY - 2020/03/26/accepted PY - 2020/4/4/pubmed PY - 2020/5/6/medline PY - 2020/4/4/entrez SP - 1405 EP - 1406 JF - Lancet (London, England) JO - Lancet VL - 395 IS - 10234 SN - 1474-547X UR - https://www.unboundmedicine.com/medline/citation/32243778/Ensuring_global_access_to_COVID_19_vaccines_ DB - PRIME DP - Unbound Medicine ER -